Caribou Biosciences Report issue

For profit Phase 1
Founded: Berkeley CA United States (2011)

Organization Overview

First Clinical Trial
2020
NCT04637763
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Caribou Biosciences, Inc.